109 related articles for article (PubMed ID: 6292563)
1. Accessory cell function in tumor-bearing mice and effects of Corynebacterium parvum.
Okuda S; Taniguchi K; Kubo C; Nomoto K
J Natl Cancer Inst; 1982 Dec; 69(6):1293-7. PubMed ID: 6292563
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
4. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
5. Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
Dimitrov NV; Denny TN; Weisman MF; Cameron DG
J Natl Cancer Inst; 1979 Aug; 63(2):423-6. PubMed ID: 379400
[TBL] [Abstract][Full Text] [Related]
6. Immunoadjuvant effects of Blastomyces dermatitidis against EL 4 lymphoma in C57BL/6J mice.
McDaniel LS; Cozad GC
J Natl Cancer Inst; 1982 Dec; 69(6):1337-42. PubMed ID: 6958909
[TBL] [Abstract][Full Text] [Related]
7. The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.
Watson SR; Sljivić VS
Clin Exp Immunol; 1976 Jan; 23(1):149-53. PubMed ID: 770033
[TBL] [Abstract][Full Text] [Related]
8. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
Likhite VV
J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
[TBL] [Abstract][Full Text] [Related]
9. Further studies on the enhancement of the antibody response in vitro by C. parvum.
Slijivíc VS; Brown CA; Watson SR
Dev Biol Stand; 1977 Apr 13-15; 38():147-52. PubMed ID: 608502
[TBL] [Abstract][Full Text] [Related]
10. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
Lee KC; Berry D
J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of Corynebacterium parvum on primary and secondary antibody responses in mice.
Ansell JD; Trail KN; McDougall CM; Inchley CJ
J Reticuloendothel Soc; 1983 Oct; 34(4):311-21. PubMed ID: 6620257
[TBL] [Abstract][Full Text] [Related]
12. Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.
Matthews TJ; Weinhold KJ; Langlois AJ; Bolognesi DP
J Natl Cancer Inst; 1985 Oct; 75(4):703-8. PubMed ID: 3862902
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
Tomecki J; Sukiennik J; Kordowiak A
Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
[TBL] [Abstract][Full Text] [Related]
14. Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.
Kirchner H; Holden HT; Herberman
J Immunol; 1975 Nov; 115(5):1212-6. PubMed ID: 1176773
[TBL] [Abstract][Full Text] [Related]
15. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
Wolmark N; Fisher B
Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
[No Abstract] [Full Text] [Related]
16. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
17. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
Miyata H; Himeno K; Miake S; Nomoto K
Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
[TBL] [Abstract][Full Text] [Related]
19. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of macrophage function by 2-chloroadenosine.
Ohtani A; Kumazawa Y; Fujisawa H; Nishimura C
J Reticuloendothel Soc; 1982 Sep; 32(3):189-200. PubMed ID: 7153986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
